Adjuvant Therapeutic Effect of Vitamin D on Hashimoto's Thyroiditis - Trial NCT05871957
Access comprehensive clinical trial information for NCT05871957 through Pure Global AI's free database. This phase not specified trial is sponsored by Qianfoshan Hospital and is currently Not yet recruiting. The study focuses on Hashimoto Thyroiditis. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Qianfoshan Hospital
Timeline & Enrollment
N/A
Jun 01, 2023
Sep 30, 2023
Primary Outcome
TPOAB in IU/ml
Summary
The purpose of this study is to explore the relationship between vitamin D and Hashimoto's
 thyroiditis and to explore whether vitamin D can play an adjuvant role in the treatment of
 Hashimoto's thyroiditis. Epidemiological surveys show that vitamin D deficiency rates are as
 high as 50%-90% in HT patients. Dietary supplementation with vitamin D has been evaluated as
 a way to protect the thyroid gland from autoimmune damage, but the results of randomized
 clinical trials are unclear.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05871957
Non-Device Trial